Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Versus Intravenous Opioid Dosing for Severe Acute Pain in the ED
NCT03257319Phase 3Completed
- Sponsor
- Rouen University Hospital
- Start
- Sep 2017
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of morphine in acute pain (2 arms), sponsored by Rouen University Hospital. Primary endpoint: Rate of relief obtained (EVA1 <= 30/100 or EN1 <= 3/10) at 1 hour. Started Sep 2017; status: completed.
02
Drugs
morphine
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT03257319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03257319.